TITLE

Late HIV Diagnosis and Determinants of Progression to AIDS or Death after HIV Diagnosis among Injection Drug Users, 33 US States, 1996-2004

AUTHOR(S)
Grigoryan, Anna; Hall, H. Irene; Durant, Tonji; Xiangming Wei
PUB. DATE
February 2009
SOURCE
PLoS ONE;2009, Vol. 4 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major determinants of survival for HIV-infected people. Injection drug users (IDUs) are less likely than persons in other transmission categories to seek early HIV counseling, testing, and treatment. Our objective was to estimate the proportion of IDUs with a late HIV diagnosis (AIDS diagnosis within 12 months of HIV diagnosis) and determine the factors associated with disease progression after HIV diagnosis. Methodology/Principal Findings: Using data from 33 states with confidential name-based HIV reporting, we determined the proportion of IDUs aged $13 years who received a late HIV diagnosis during 1996-2004. We used standardized Kaplan- Meier survival methods to determine differences in time of progression from HIV to AIDS and death, by race/ethnicity, sex, age group, CD4+ T-cell count, metropolitan residence, and diagnosis year. We compared the survival of IDUs with the survival of persons in other transmission categories. During 1996-2004, 42.2% (11,635) of 27,572 IDUs were diagnosed late. For IDUs, the risk for progression from HIV to AIDS 3 years after HIV diagnosis was greater for nonwhites, males and older persons. Three-year survival after HIV diagnosis was lower for IDU males (87.3%, 95% confidence interval (CI), 87.1-87.4) compared with males exposed through male-to-male sexual contact (91.6%, 95% CI, 91.6-91.7) and males exposed through high-risk heterosexual contact (HRHC) (91.9%, 95% CI, 91.8-91.9). Survival was also lower for IDU females (89.5%, 95% CI, 89.4-89.6) compared to HRHC females (93.3%, 95% CI, 93.3-93.4). Conclusions/Significance: A substantial proportion of IDUs living with HIV received their HIV diagnosis late. To improve survival of IDUs, HIV prevention efforts must ensure early access to HIV testing and care, as well as encourage adherence to antiretroviral treatment to slow disease progression.
ACCESSION #
55666495

 

Related Articles

  • Cost-Effectiveness of Early Infant HIV Diagnosis of HIV-Exposed Infants and Immediate Antiretroviral Therapy in HIV-Infected Children under 24 Months in Thailand. Collins, Intira Jeannie; Cairns, John; Ngo-Giang-Huong, Nicole; Sirirungsi, Wasna; Leechanachai, Pranee; Le Coeur, Sophie; Samleerat, Tanawan; Kamonpakorn, Nareerat; Mekmullica, Jutarat; Jourdain, Gonzague; Lallemant, Marc // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background: HIV-infected infants have high risk of death in the first two years of life if untreated. WHO guidelines recommend early infant HIV diagnosis (EID) of all HIV-exposed infants and immediate antiretroviral therapy (ART) in HIV-infected children under 24-months. We assessed the...

  • The incidence of AIDS in Portugal adjusted for reporting delay and underreporting. Oliveira, Alexandra; Costa, Joaquim; Gaio, Ana Rita // CISTI (Iberian Conference on Information Systems & Technologies ;2014, Vol. 1, p1035 

    The Human Immunodeficiency Virus can evolve to severe illness having a major impact on socio-demographic and economic features of the affected countries. Most countries rely on surveillance systems to monitor the status of the epidemic which are based on cases notification by physicians. It can...

  • Intensive Tuberculosis Screening for HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa. Bassett, Ingrid V.; Wang, Bingxia; Chetty, Senica; Giddy, Janet; Losina, Elena; Mazibuko, Matilda; Bearnot, Benjamin; Allen, Jenny; Walensky, Rochelle P.; Freedberg, Kenneth A. // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p823 

    Background. The World Health Organization (WHO) recommends cough as the trigger for tuberculosis screening in human immunodeficiency virus (HIV)-infected patients, with acid-fast bacillus (AFB) smear as the initial diagnostic test. Our objective was to assess the yield and cost of a more...

  • ERRATUM.  // Journal of Infectious Diseases;11/1/2016, Vol. 214 Issue 9, p1465 

    A correction to the article "Role of public-private partnerships in meeting healthcare challenges in Africa: a perspective from the public sector" that was published in the 2016 issue is presented.

  • Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection. Lodi, Sara; Fisher, Martin; Phillips, Andrew; De Luca, Andrea; Ghosn, Jade; Malyuta, Ruslan; Zangerle, Robert; Moreno, Santiago; Vanhems, Philippe; Boufassa, Faroudy; Guiguet, Marguerite; Porter, Kholoud // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Background: The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking. Methods: CASCADE patients with HIV test interval <6 months were...

  • Cheaper diagnostics. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;7/12/2011, Vol. 183 Issue 10, pE654 

    The article reports on the initiative to push for cheaper diagnostics of HIV and AIDS testing in poor countries.

  • γδ T Cells Are Involved in Acute HIV Infection and Associated with AIDS Progression. Li, Zhen; Li, Wei; Li, Ning; Jiao, Yanmei; Chen, Dexi; Cui, Lianxian; Hu, Yu; Wu, Hao; He, Wei // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background: Early diagnosis is vital to HIV control. γδ T cells play critical roles in viral infections, but their activation in acute HIV infected patients and follow up to 18 months has not been described. Methods: Changes in γδ T cells, including subsets, function and...

  • Evaluación de la Consejería Pretest para el VIH en un Hospital Nacional en Lima-Perú. Mora-Salazar, Otto E.; Palomino-Vargast, Jorge D.; Velásquez-Ruiz, Cecilia M.; Gómez-Pomar, Enrique M.; Castillo-Schilder, Rosa M.; Soto-Arquiñigo, Leslie; Samalvides-Cuba, Frine // Revista de Salud Pública;jul/aug2009, Vol. 11 Issue 4, p559 

    Objective Evaluating the knowledge acquired by the pre-test counselling programme in a national hospital in Lima Peru. Method A cross-sectional descriptive observational study was carried out on 499 patients attending the National STI/HIV Prevention and Control Sanitary Strategy service after...

  • Correction: HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy? null, null // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics